|
|
||||||||
AJP - Endocrinology and Metabolism, Vol 265, Issue 4 E592-E600, Copyright © 1993 by American Physiological Society
ARTICLES |
A. B. Jenkins, L. H. Storlien, G. J. Cooney, G. S. Denyer, I. D. Caterson and E. W. Kraegen
Garvan Institute of Medical Research, St. Vincent's Hospital, Sydney, New South Wales, Australia.
We examined the effect of the long-chain fatty acid oxidation blocker methyl palmoxirate (methyl 2-tetradecyloxiranecarboxylate, McN-3716) on glucose metabolism in conscious rats. Fasted animals [5 h with or without hyperinsulinemia (100 mU/l) and 24 h] received methyl palmoxirate (30 or 100 mg/kg body wt po) or vehicle 30 min before a euglycemic glucose clamp. Whole body and tissue-specific glucose metabolism were calculated from 2-deoxy-[3H]-glucose kinetics and accumulation. Oxidative metabolism was assessed by respiratory gas exchange in 24-h fasted animals. Pyruvate dehydrogenase complex activation was determined in selected tissues. Methyl palmoxirate suppressed whole body lipid oxidation by 40-50% in 24-h fasted animals, whereas carbohydrate oxidation was stimulated 8- to 10-fold. Whole body glucose utilization was not significantly affected by methyl palmoxirate under any conditions; hepatic glucose output was suppressed only in the predominantly gluconeogenic 24-h fasted animals. Methyl palmoxirate stimulated glucose uptake in heart in 24-h fasted animals [15 +/- 5 vs. 220 +/- 28 (SE) mumol x 100 g-1 x min-1], with smaller effects in 5-h fasted animals with or without hyperinsulinemia. Methyl palmoxirate induced significant activation of pyruvate dehydrogenase in heart in the basal state, but not during hyperinsulinemia. In skeletal muscles, methyl palmoxirate suppressed glucose utilization in the basal state but had no effect during hyperinsulinemia; pyruvate dehydrogenase activation in skeletal muscle was not affected by methyl palmoxirate under any conditions. The responses in skeletal muscle are consistent with the operation of a mechanism similar to the Pasteur effect.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
![]() |
M. Christopher, C. Rantzau, Z.-P. Chen, R. Snow, B. Kemp, and F. P. Alford Impact of in vivo fatty acid oxidation blockade on glucose turnover and muscle glucose metabolism during low-dose AICAR infusion Am J Physiol Endocrinol Metab, November 1, 2006; 291(5): E1131 - E1140. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Koyama, G. Chen, Y. Lee, and R. H. Unger Tissue triglycerides, insulin resistance, and insulin production: implications for hyperinsulinemia of obesity Am J Physiol Endocrinol Metab, October 1, 1997; 273(4): E708 - E713. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Meyer, M. Stumvoll, J. Dostou, S. Welle, M. Haymond, and J. Gerich Renal substrate exchange and gluconeogenesis in normal postabsorptive humans Am J Physiol Endocrinol Metab, February 1, 2002; 282(2): E428 - E434. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |